Skip navigation
中文
English
DSpace
CRIS
Home
Organizations
Researchers
Research Outputs
Explore by
Organizations
Researchers
Research Outputs
Academic & Publications
Help
Sign in
中文
English
NTU Scholars
Research Outputs
Browsing by Author
Su Y.-J.
or enter first few letters:
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 11 of 11
Issue Date
Title
Author(s)
Source
scopus
WOS
Fulltext/Archive link
2015
Activation of mitochondrial STAT-3 and reduced mitochondria damage during hypothermia treatment for post-cardiac arrest myocardial dysfunction
CHIEN-HUA HUANG
; MIN-SHAN TSAI
; Chiang C.-Y.; Su Y.-J.; TZUNG-DAU WANG
; WEI-TIEN CHANG
; HUEI-WEN CHEN
; WEN-JONE CHEN
Basic Research in Cardiology
30
31
2016
Correction to Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties [Oncotarget. 6, 35 (2015) 38029-45, DOI: 10.18632/oncotarget.5703]
Su Y.-J.; WEI-HSIN LIN
; Chang Y.-W.; Wei K.-C.; Liang C.-J.; Chen S.-C.; Lee J.-L.
Oncotarget
2
2
2015
Diverse targets of β-catenin during the epithelial-mesenchymal transition define cancer stem cells and predict disease relapse
Chang Y.-W.; Su Y.-J.; Hsiao M.; Wei K.-C.; WEI-HSIN LIN
; Liang C.-L.; Chen S.-C.; Lee J.-L.
Cancer Research
74
66
2010
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
JEN-CHUNG KO
; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
Lung Cancer
48
43
2009
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation
Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHUNG KO
; Lin Y.-W.
Experimental Cell Research
28
26
2015
Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties
Su Y.-J.; WEI-HSIN LIN
; Chang Y.-W.; Wei K.-C.; Liang C.-L.; Chen S.-C.; Lee J.-L.
Oncotarget
48
51
2011
Post-cardiac arrest myocardial dysfunction is improved with cyclosporine treatment at onset of resuscitation but not in the reperfusion phase
CHIEN-HUA HUANG
; MIN-SHAN TSAI
; Hsu C.-Y.; Su Y.-J.; TZUNG-DAU WANG
; WEI-TIEN CHANG
; WEN-JONE CHEN
Resuscitation
28
0
2009
Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells
JEN-CHUNG KO
; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
Molecular Cancer Research
45
40
2021
SMARCB1(INI1)-deficient sinonasal adenocarcinoma: Report of a case previously diagnosed as high-grade non-intestinal-type sinonasal adenocarcinoma
Su Y.-J.; Lee Y.-H.; MIN-SHU HSIEH
Pathology International
1
1
2010
Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells
JEN-CHUNG KO
; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
Biochemical Pharmacology
71
62
2022
Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma
Su Y.-J.; Lee Y.-H.; Jin Y.-T.; MIN-SHU HSIEH
Applied Immunohistochemistry and Molecular Morphology
5
3